A Rapid-Response Tool for Influenza Protection
Author Information
Author(s): Zhang Jianfeng, Tarbet E. Bart, Feng Tsungwei, Shi Zhongkai, Van Kampen Kent R., Tang De-chu C.
Primary Institution: Vaxin, Inc.
Hypothesis
Can an adenovirus-vectored drug-vaccine duo confer rapid and sustained protection against influenza?
Conclusion
The adenovirus-vectored drug-vaccine duo can provide rapid protection against influenza and elicit sustained immunity.
Supporting Evidence
- Intranasal administration of adenovirus particles protected 100% of mice against a lethal dose of influenza.
- The protective effects of the adenovirus-vectored duo persisted for several weeks.
- Statistical significance was reached when comparing treated mice to untreated controls.
Takeaway
This study shows that a special nasal spray can help protect mice from the flu quickly and keep them safe for a long time.
Methodology
Mice were administered adenovirus particles intranasally and then challenged with influenza virus to assess protection.
Potential Biases
Potential conflicts of interest due to authors' affiliations with Vaxin, Inc.
Limitations
The study was conducted in mice, and results may not directly translate to humans.
Participant Demographics
Young female Balb/c mice were used in the study.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website